Literature DB >> 24970383

Cannabis policy reforms in the Americas: a comparative analysis of Colorado, Washington, and Uruguay.

Bryce Pardo1.   

Abstract

Legal reforms in the Americas are influencing the public debate on cannabis policy. Uruguay and the two US states of Colorado and Washington have taken steps to regulate and legitimize the production, distribution, and use of cannabis and its derivatives. Earlier experiences with medical cannabis in the United States and limited access and production models in Europe have been insightful. However, these reforms are going further still, venturing into a new area of cannabis policy. A lack of empirical evidence regarding the effects of such reforms poses a challenge for policymakers. These examples will inform the design and implementation of any future cannabis policies. Therefore, a clear understanding of the details of each jurisdiction is necessary in developing future legal changes. Literature comparing the models of Uruguay, Colorado, and Washington is thin. This paper is based on an exhaustive examination of the laws, regulations, and discussions with regulators and functionaries of each jurisdiction. The research and analysis herein will provide policymakers with a greater understanding of the laws and regulations relevant to legal cannabis in these three jurisdictions, as well as draw to their attention some potential impacts and challenges of cannabis reform that require additional consideration to ensure public safety and health.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Access to cannabis; Cannabis; International drug control; Policy; Regulation

Mesh:

Year:  2014        PMID: 24970383     DOI: 10.1016/j.drugpo.2014.05.010

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  23 in total

1.  Cannabis legalization: adhering to public health best practice.

Authors:  Sheryl Spithoff; Brian Emerson; Andrea Spithoff
Journal:  CMAJ       Date:  2015-09-21       Impact factor: 8.262

Review 2.  Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.

Authors:  Benedikt Fischer; Cayley Russell; Pamela Sabioni; Wim van den Brink; Bernard Le Foll; Wayne Hall; Jürgen Rehm; Robin Room
Journal:  Am J Public Health       Date:  2017-06-23       Impact factor: 9.308

3.  Assessing the public health impact of cannabis legalization in Canada: core outcome indicators towards an 'index' for monitoring and evaluation.

Authors:  Benedikt Fischer; Cayley Russell; Jürgen Rehm; Pamela Leece
Journal:  J Public Health (Oxf)       Date:  2019-06-01       Impact factor: 2.341

4.  Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.

Authors:  Daniel G Orenstein; Stanton A Glantz
Journal:  J Psychoactive Drugs       Date:  2018-02-13

5.  The effects of recreational cannabis legalization might depend upon the policy model.

Authors:  Rosario Queirolo
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

6.  Assessing the public health impacts of legalizing recreational cannabis use: the US experience.

Authors:  Wayne Hall; Michael Lynskey
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

Review 7.  Impacts of Changing Marijuana Policies on Alcohol Use in the United States.

Authors:  Katarina Guttmannova; Christine M Lee; Jason R Kilmer; Charles B Fleming; Isaac C Rhew; Rick Kosterman; Mary E Larimer
Journal:  Alcohol Clin Exp Res       Date:  2015-12-21       Impact factor: 3.455

8.  Marijuana Regulatory Frameworks in Four US States: An Analysis Against a Public Health Standard.

Authors:  Rachel A Barry; Stanton A Glantz
Journal:  Am J Public Health       Date:  2018-07       Impact factor: 9.308

9.  Differences in patterns of cannabis use among youth: Prevalence, perceptions of harm and driving under the influence in the USA where non-medical cannabis markets have been established, proposed and prohibited.

Authors:  Elle Wadsworth; David Hammond
Journal:  Drug Alcohol Rev       Date:  2018-07-10

Review 10.  Public health and international drug policy.

Authors:  Joanne Csete; Adeeba Kamarulzaman; Michel Kazatchkine; Frederick Altice; Marek Balicki; Julia Buxton; Javier Cepeda; Megan Comfort; Eric Goosby; João Goulão; Carl Hart; Thomas Kerr; Alejandro Madrazo Lajous; Stephen Lewis; Natasha Martin; Daniel Mejía; Adriana Camacho; David Mathieson; Isidore Obot; Adeolu Ogunrombi; Susan Sherman; Jack Stone; Nandini Vallath; Peter Vickerman; Tomáš Zábranský; Chris Beyrer
Journal:  Lancet       Date:  2016-03-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.